Anti- Rituximab (Anti-Idiotype) Antibody, R&D Systems™

Rabbit Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB9630SP	R&D Systems MAB9630SP	25 μg
MAB9630100	R&D Systems MAB9630100	100 μg

Description

Rituximab Monoclonal specifically detects Rituximab in Multi-Species samples. It is validated for Western Blot, Flow Cytometry, ELISA, Binding Inhibition.

Specifications

• Antigen: Rituximab
• Dilution: Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
• Classification: Monoclonal
• Form: Supernatant
• Target Species: Multi-species
• Gene Alias: B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
• Isotype: IgG
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

• Clone: 2260A
• Applications: Western Blot, Flow Cytometry, ELISA
• Conjugate: Unconjugated
• Host Species: Rabbit
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
• Immunogen: Full-length Rituximab
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.